Indivior
INDV
0.00
+0.91
+2.57%
Indivior
US · INDV
#2252 by market cap
Listed 1970
0.00
+0.91
+2.57%
Snapshot may be outdated; check the quote time before use.
· 2026-11-02 19:54
Recent news
-
Rating change
Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/2/28
-
Rating change
Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $54Market Newswire · 2026/3/18
-
Rating change
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/1/9
-
Rating change
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $53Market Newswire · 2026/8/4
-
Rating change
Barclays Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $43Market Newswire · 2026/8/5
-
Rating change
H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $48Market Newswire · 2026/8/4
-
Rating change
Morgan Stanley Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2025/12/3
-
Company notice
Indivior: Indivior Pharmaceuticals, Inc. - Cash Distribution and Name/Symbol Change Option Symbol: INDV New Symbol: SUPNOCC · 2026/11/3
-
Rating change
H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $48Market Newswire · 2026/1/14
-
Craig-Hallum Maintains Indivior(INDV.US) With Buy RatingMarket Newswire · 2026/9/18
-
Rating change
Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $59Market Newswire · 2026/5/22
-
Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Posts Q3 Adjusted EPS $1.32 per Share, Vs. FactSet Est of $1.06MT Newswires · 2026/10/29
-
Company notice
Indivior: Indivior Pharmaceuticals, Inc. - Anticipated Cash Distribution Option Symbol: INDVOCC · 2026/10/10
-
News On Indivior Pharmaceuticals Inc. (INDV) Now Under SUPNDow Jones · 2026/11/4
-
GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B to $1.37B, Vs. FactSet Est of $1.33BMT Newswires · 2026/10/29
-
Rating change
Barclays Initiates Indivior(INDV.US) With Buy Rating, Announces Target Price $46Market Newswire · 2026/6/18
-
Barclays Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $45Market Newswire · 2026/10/28
-
Rating change
Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $41Market Newswire · 2025/12/4
-
Rating change
Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $50Market Newswire · 2026/1/20
-
Rating change
Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2025/12/19
-
Rating change
Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $41Market Newswire · 2025/10/31
-
Rating change
H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2025/10/31
-
Rating change
Jefferies Initiates Indivior(INDV.US) With Buy Rating, Announces Target Price $20Market Newswire · 2025/7/22
-
Rating change
Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $22Market Newswire · 2025/7/1
-
Rating change
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $22Market Newswire · 2025/7/1
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-02 19:54:59 · For reference only, not investment advice and not tailored to your situation.
Indivior discussion 0 comments